More headlines

  • Actavis buying Warner Chilcott in $8.5B deal
    Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
  • Ryanair keeps growing, reports record profits
    Ryanair reported record profits Monday as Europe's largest budget airline expanded its route network across the continent and into North Africa.
  • Royalty Pharma increases bid for drugmaker Elan
    Royalty Pharma is raising its offer to buy Elan on the condition that shareholders reject the Irish drugmaker's push to refocus its business through a string of recently announced deals.
Advertisement
Sorry, this article is no longer available.

Advertisement